Cite
HARVARD Citation
Nam, S. et al. (n.d.). An increase in indoleamine 2, 3-dioxygenase-positive cells in the tumor microenvironment predicts favorable prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone. Leukemia & lymphoma. 57 (8), pp. 1956-1960. [Online].